UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 8.477

Sortiert nach

Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence

The New England journal of medicine, 2023-03, Vol.388 (9), p.781-791

2023

Volltextzugriff (PDF)

Using Fixed-Dose Combination Therapies to Achieve Blood Pressure Goals

Clinical drug investigation, 2008-01, Vol.28 (11), p.713-734

Chrysant, Steven G.

2008

Volltextzugriff (PDF)

Occurrence and removal of pharmaceuticals and hormones through drinking water treatment

Water research (Oxford), 2011-01, Vol.45 (3), p.1432-1442

2011

Volltextzugriff (PDF)

Facile formation of co-amorphous atenolol and hydrochlorothiazide mixtures via cryogenic-milling: Enhanced physical stability, dissolution and pharmacokinetic profile

International journal of pharmaceutics, 2017-10, Vol.532 (1), p.393-400

2017

Volltextzugriff (PDF)

Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy

Drug delivery, 2018-01, Vol.25 (1), p.1910-1921

2018

Volltextzugriff (PDF)

Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes

Diabetes, obesity & metabolism, 2013-09, Vol.15 (9), p.853-862

2013

Volltextzugriff (PDF)

WHO BIOWAIVER PROJECT - PRIORITIZATION EXERCISE OF ACTIVE PHARMACEUTICAL INGREDIENTS FOR CYCLE VI

WHO drug information, 2023-12, Vol.37 (4), p.938

2023

Volltextzugriff (PDF)

Development and in vivo evaluation of an innovative “Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles” formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics

International journal of pharmaceutics, 2017-04, Vol.521 (1-2), p.73-83

2017

Volltextzugriff (PDF)

Chlorthalidone vs. Hydrochlorothiazide for Hypertension–Cardiovascular Events

The New England journal of medicine, 2022-12, Vol.387 (26), p.2401-2410

2022

Volltextzugriff (PDF)

Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans

The New England journal of medicine, 2019-06, Vol.380 (25), p.2429-2439

2019

Volltextzugriff (PDF)

Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial

The Lancet (British edition), 2013-02, Vol.381 (9866), p.537-545

2013

Volltextzugriff (PDF)

Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark

Journal of the American Academy of Dermatology, 2018-04, Vol.78 (4), p.673-681.e9

2018

Volltextzugriff (PDF)

Facile immunochromatographic assay based on metal–organic framework-decorated polydopamine for the determination of hydrochlorothiazide adulteration in functional foods

Food chemistry, 2023-04, Vol.406, p.135100-135100, Article 135100

2023

Volltextzugriff (PDF)

Safety and human health: The landscape of an effective UPLC-MS/MS method for the identification and quantification of N-Nitroso Hydrochlorothiazide impurity in Hydrochlorothiazide

Journal of King Saud University. Science, 2024-10, Vol.36 (9), p.103349, Article 103349

2024

Volltextzugriff (PDF)

Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension

JAMA internal medicine, 2020-04, Vol.180 (4), p.542

2020

Volltextzugriff (PDF)

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

The New England journal of medicine, 2016-05, Vol.374 (21), p.2009-2020

2016

Volltextzugriff (PDF)

Polypill with or without Aspirin in Persons without Cardiovascular Disease

The New England journal of medicine, 2021-01, Vol.384 (3), p.216-228

2021

Volltextzugriff (PDF)

Constituents of IChimaphila japonica/I and Their Diuretic Activity

Molecules (Basel, Switzerland), 2024-02, Vol.29 (5)

2024

Volltextzugriff (PDF)

Influence of formulation variables on the processability and properties of tablets manufactured by fused deposition modelling

International journal of pharmaceutics, 2023-04, Vol.637, p.122854-122854, Article 122854

2023

Volltextzugriff (PDF)

Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial

The Lancet (British edition), 2019-08, Vol.394 (10199), p.672-683

2019

Volltextzugriff (PDF)

Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease

The New England journal of medicine, 2016-05, Vol.374 (21), p.2032-2043

2016

Volltextzugriff (PDF)

Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension

Cochrane database of systematic reviews, 2014-05, Vol.2014 (5), p.CD003824

2014

Volltextzugriff (PDF)

Hydrochlorothiazide binding to human serum albumin induces some compactness in the molecular structure of the protein: A multi-spectroscopic and computational study

Journal of pharmaceutical and biomedical analysis, 2019-01, Vol.162, p.1-8

2019

Volltextzugriff (PDF)

Evaluation of Drug-Drug Interaction Between Henagliflozin and Hydrochlorothiazide in Healthy Chinese Volunteers

Drug design, development and therapy, 2024-06, Vol.18, p.1855-1864

2024

Volltextzugriff (PDF)

DEVELOPMENT OF RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF NEBIVOLOL HYDROCHLORIDE, VALSARTAN AND HYDROCHLOROTHIAZIDE IN CO-ADMINISTRATED ANTIHYPERTENSIVE AGENTS AND HUMAN PLASMA

Bulletin of pharmaceutical sciences, 2023-06, Vol.46 (1), p.157-172

2023

Volltextzugriff (PDF)

1 – 25 von 8.477

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.746)
Mit Volltextzugriff
(5.351)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(5.452)
Science & Technology
(5.276)
Life Sciences & Biomedicine
(4.942)
Male
(3.876)
Hydrochlorothiazide
(3.577)
Female
(3.296)
Hypertension - Drug Therapy
(3.246)
Hydrochlorothiazide - Therapeutic Use
(3.120)
Middle Aged
(2.951)
Adult
(2.195)
Aged
(2.083)
Blood Pressure - Drug Effects
(1.680)
Hypertension
(1.602)
Drug Therapy, Combination
(1.560)
Pharmacology & Pharmacy
(1.524)
Biological And Medical Sciences
(1.494)
Medical Sciences
(1.455)
Hydrochlorothiazide - Administration & Dosage
(1.444)
Cardiovascular System & Cardiology
(1.318)
Hydrochlorothiazide - Adverse Effects
(1.291)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(44)

Menü

Weitere Dienste

Einstellungen

Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence

Using Fixed-Dose Combination Therapies to Achieve Blood Pressure Goals

Occurrence and removal of pharmaceuticals and hormones through drinking water treatment

Facile formation of co-amorphous atenolol and hydrochlorothiazide mixtures via cryogenic-milling: Enhanced physical stability, dissolution and pharmacokinetic profile

Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy

Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes

WHO BIOWAIVER PROJECT - PRIORITIZATION EXERCISE OF ACTIVE PHARMACEUTICAL INGREDIENTS FOR CYCLE VI

Development and in vivo evaluation of an innovative “Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles” formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics

Chlorthalidone vs. Hydrochlorothiazide for Hypertension–Cardiovascular Events

Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans

Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial

Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark

Facile immunochromatographic assay based on metal–organic framework-decorated polydopamine for the determination of hydrochlorothiazide adulteration in functional foods

Safety and human health: The landscape of an effective UPLC-MS/MS method for the identification and quantification of N-Nitroso Hydrochlorothiazide impurity in Hydrochlorothiazide

Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

Polypill with or without Aspirin in Persons without Cardiovascular Disease

Constituents of IChimaphila japonica/I and Their Diuretic Activity

Influence of formulation variables on the processability and properties of tablets manufactured by fused deposition modelling

Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial

Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease

Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension

Hydrochlorothiazide binding to human serum albumin induces some compactness in the molecular structure of the protein: A multi-spectroscopic and computational study

Evaluation of Drug-Drug Interaction Between Henagliflozin and Hydrochlorothiazide in Healthy Chinese Volunteers

DEVELOPMENT OF RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF NEBIVOLOL HYDROCHLORIDE, VALSARTAN AND HYDROCHLOROTHIAZIDE IN CO-ADMINISTRATED ANTIHYPERTENSIVE AGENTS AND HUMAN PLASMA

Suchergebnisse filtern